Ajanta Pharma’s Net Profit Falls By 19% In Q4, While R&D Cost Increases By 7%
The mid-sized company, Ajanta Pharma ended today’s trading session with a market value of 16,201.44 crore. It is a specialised pharmaceutical company that provides top-notch medicines in more than 30 different countries throughout the world. Ajanta Pharma said that its net profit stood at Rs 122 crore during Q4FY23 down by 14 per cent YoY […]